Begin main content

News and Events

Latest News

New Opportunity: Parallel Scientific Advice From CADTH and NICE

February 6, 2019
CADTH is pleased to announce a new collaboration with England’s NICE (National Institute for Health and Care Excellence) to offer parallel scientific advice to pharmaceutical companies. Through this new initiative, participating pharmaceutical companies will receive advice simultaneously from CADTH and NICE to facilitate evidence generation for ...

Nominations now open for Patient and Community Advisory Committee

January 28, 2019
CADTH is currently seeking individuals with diverse experiences with the Canadian health care system for our Patient and Community Advisory Committee. This newly established committee will provide CADTH with advice on issues relevant to CADTH’s mandate, from the perspectives of those using the Canadian health care system. We encourage all those ...

Call for Patient Input and Clinical Experts: Kynmobi

January 25, 2019
CADTH has received the following notice(s) of pending drug submission(s).  Brand name Kynmobi Generic name apomorphine hydrochloride Manufacturer Sunovion Pharmaceuticals Canada Inc. Indication(s) Parkinson’s Disease Project Number SR0604-000 Call for patient input 2019-01-25 Patient input deadline 2019-03-18 Submit patient input Submit Register...

Upcoming Events

2019 CADTH Symposium

April 14, 2019 - April 16, 2019
CADTH will be hosting its annual Symposium at the Shaw Centre in Edmonton, Alberta, from April 14 to 16, 2019. For more information, please visit the CADTH Symposium website. Questions may be sent by email to